(Q43056445)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20494511%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

title

A novel compound modified from tanshinone inhibits tumor growth in vivo via activation of the intrinsic apoptotic pathway (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20494511%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20494511%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

author name string

Hong-Lei Tian

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20494511%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Ting Yu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20494511%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Nai-Ning Xu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20494511%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Li-Ying Zhou

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20494511%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Hou-Wei Luo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20494511%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Donald C Chang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20494511%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Xiao-Feng Le

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20494511%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Kathy Qian Luo

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20494511%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

language of work or name

English

0 references

publication date

21 May 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20494511%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20494511%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

volume

297

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20494511%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20494511%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

page(s)

18-30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20494511%20AND%20SRC:MED&resulttype=core&format=json

Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines

3 February 2020

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1093/JNCI/83.11.757

Identifiers

DOI

10.1016/J.CANLET.2010.04.020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20494511%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1 reference